Wednesday, February 15, 2012

A Biotech That May Boost an Anemic Portfolio

Celgene Corp. (NASDAQ:CELG) is in an aggressive bull market and recently flashed
another buy signal.

No comments:

Post a Comment

LinkWithin

Related Posts Plugin for WordPress, Blogger...